Vaccine-induced Myocarditis and Postural Orthostatic Tachycardia Syndrome

A study published in January 2023 found that people who developed myocarditis after receiving a coronavirus vaccine had significantly higher levels of the virus's spike protein that was not bound by immune antibodies. It was also found in 10% of patients with chronic Hepatitis C up to 28 days after COVID-19 vaccination. 

The spike protein may damage the heart's pericytes or endothelium by reducing the expression of the angiotensin-converting enzyme 2 (ACE2), reducing the production of nitric oxide in the endothelium, or activating integrin-mediated inflammation with hyperpermeability of the endothelial cell layer. The study prospectively collected blood from 16 patients with myocarditis who were hospitalized at two hospitals in Massachusetts (2 after the 1st dose, 12 after the second dose, and 2 after the 3rd dose) and compared the results to those from 45 vaccinated control subjects with no serious side effects. The individuals with myocarditis had essentially the same antibody and T-cell responses as the control subjects but had markedly higher levels of unbound spike protein and higher cytokine production. No unbound spike protein was detected in the control subjects. The authors suggest that administration of anti-spike antibodies, if spike antigen-emia  is  detected, could potentially prevent or reverse postvaccine myocarditis."

One of the latest published case reports about post-vaccinal myocarditis described a 13-year-old male who developed fever, headache, fatigue, and sleep disturbance on the day after receiving a second dose of the Pfizer-BioNTech COVID-19 mRNA vaccine. 2 weeks later he presented at a clinic and was treated with Acetaminophen, ibuprofen, and Chinese herbs (Goreisan and Kakkonto) but the symptoms persisted, and the patient was unable to get out of bed all day. An active standing test (AST) showed that when the patient stood, his heart rate immediately increased from 65 to 140 beats/minute  (bpm). Motor nerve and sensory nerve conduction studies showed no abnormalities (see Figure). He was diagnosed with postural orthostatic tachycardia syndrome (POTS). On the 33rd day after vaccination, despite complying with the POTS regime, he was admitted to the hospital due to severe fatigue, headache, and orthostatic symptoms including lightheadedness and palpitations. Echocardiography revealed a slight pericardial effusion (3-5 mm) at the right anterior ventricle, with a 72% normal ejection fraction leading to a diagnosis of mild myocarditis.

The patient's symptoms improved after intravenous immunoglobulin for myocarditis, non-pharmacologic interventions, and multiple medications for POTS.

Another recent paper showed that in the vaccinated senior high school students, the depolarization and repolarization parameters (QRS duration and QT interval) decreased significantly after the vaccine with increasing heart rate. In total, 763 students (17.1%) had at least one cardiac symptom after the second vaccine dose, mostly chest pain and palpitations. Recent reviews highlighted the risk in males under 40 and in children and adolescents. 


REFERENCES

Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, Davis JP, Loiselle M, Novak T, Senussi Y, Cheng CA, Burgess E, Edlow AG, Chou J, Dionne A, Balaguru D, Lahoud-Rahme M, Arditi M, Julg B, Randolph AG, Alter G, Fasano A, Walt DR. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. Circulation. 2023 Jan 4. doi: 10.1161/CIRCULATIONAHA.122.061025. Epub ahead of print. PMID: 36597886.

Sanada Y, Azuma J, Hirano Y, Hasegawa Y, Yamamoto T. Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report. Cureus. 2022 Nov 2;14(11):e31006. doi: 10.7759/cureus.31006. PMID: 36475233; PMCID: PMC9717213.


Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis ...
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an incr...
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high ...
Read more